CalciMedica (CALC) Enterprise Value (QoQ) (2020 - 2026)
CalciMedica (CALC) Enterprise Value (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | CalciMedica | 9.71 Mn | -8.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -127.04% |
| Mar 31, 2026 | 37.28% |
| Dec 31, 2025 | 7.58% |
| Sep 30, 2025 | 53.11% |
| Jun 30, 2025 | -21.99% |
| Mar 31, 2025 | -31.90% |
| Dec 31, 2024 | 6.90% |
| Sep 30, 2024 | -4.78% |
| Jun 30, 2024 | 25.57% |
| Mar 31, 2024 | -128.78% |
| Dec 31, 2023 | 22.98% |
| Sep 30, 2023 | 23.61% |
| Jun 30, 2023 | 56.57% |
| Sep 30, 2022 | 9.41% |
| Jun 30, 2022 | 22.92% |
| Mar 31, 2022 | 12.74% |
| Dec 31, 2021 | 24.10% |
| Sep 30, 2021 | 1.40% |
| Jun 30, 2021 | 14.12% |
| Mar 31, 2021 | 9.83% |